nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—CA6—saliva—nicotine dependence	0.125	0.341	CbGeAlD
Furosemide—Polydipsia—Varenicline—nicotine dependence	0.0522	0.0824	CcSEcCtD
Furosemide—Pancreatitis acute—Varenicline—nicotine dependence	0.0351	0.0553	CcSEcCtD
Furosemide—Thrombosis—Varenicline—nicotine dependence	0.0229	0.0361	CcSEcCtD
Furosemide—CA7—midbrain—nicotine dependence	0.0203	0.0555	CbGeAlD
Furosemide—Nephrolithiasis—Varenicline—nicotine dependence	0.0201	0.0318	CcSEcCtD
Furosemide—Glycosuria—Varenicline—nicotine dependence	0.02	0.0315	CcSEcCtD
Furosemide—Disturbance in attention—Varenicline—nicotine dependence	0.0187	0.0295	CcSEcCtD
Furosemide—CA14—midbrain—nicotine dependence	0.0169	0.0462	CbGeAlD
Furosemide—PGD—cardiovascular system—nicotine dependence	0.016	0.0437	CbGeAlD
Furosemide—CA5B—cardiovascular system—nicotine dependence	0.0152	0.0414	CbGeAlD
Furosemide—Urine output increased—Varenicline—nicotine dependence	0.0146	0.0231	CcSEcCtD
Furosemide—Mental disability—Varenicline—nicotine dependence	0.014	0.0222	CcSEcCtD
Furosemide—Diabetes mellitus—Varenicline—nicotine dependence	0.0135	0.0213	CcSEcCtD
Furosemide—CA1—cardiovascular system—nicotine dependence	0.0134	0.0366	CbGeAlD
Furosemide—Polyuria—Varenicline—nicotine dependence	0.0134	0.0211	CcSEcCtD
Furosemide—Deafness—Varenicline—nicotine dependence	0.0131	0.0207	CcSEcCtD
Furosemide—CA7—brain—nicotine dependence	0.0128	0.0349	CbGeAlD
Furosemide—PGD—midbrain—nicotine dependence	0.0125	0.0341	CbGeAlD
Furosemide—Thirst—Varenicline—nicotine dependence	0.0123	0.0195	CcSEcCtD
Furosemide—Lethargy—Varenicline—nicotine dependence	0.012	0.0189	CcSEcCtD
Furosemide—Irritability—Varenicline—nicotine dependence	0.0112	0.0177	CcSEcCtD
Furosemide—Urinary retention—Varenicline—nicotine dependence	0.0112	0.0176	CcSEcCtD
Furosemide—Hypokalaemia—Varenicline—nicotine dependence	0.0107	0.0169	CcSEcCtD
Furosemide—CA14—brain—nicotine dependence	0.0106	0.029	CbGeAlD
Furosemide—Cramp muscle—Varenicline—nicotine dependence	0.0106	0.0167	CcSEcCtD
Furosemide—CA4—cardiovascular system—nicotine dependence	0.0105	0.0286	CbGeAlD
Furosemide—Abdominal distension—Varenicline—nicotine dependence	0.0102	0.0161	CcSEcCtD
Furosemide—SLC12A1—brain—nicotine dependence	0.00956	0.0261	CbGeAlD
Furosemide—Pollakiuria—Varenicline—nicotine dependence	0.00938	0.0148	CcSEcCtD
Furosemide—Photosensitivity reaction—Varenicline—nicotine dependence	0.00927	0.0146	CcSEcCtD
Furosemide—SLC22A6—brain—nicotine dependence	0.00927	0.0253	CbGeAlD
Furosemide—Hyperglycaemia—Varenicline—nicotine dependence	0.00916	0.0145	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00898	0.0142	CcSEcCtD
Furosemide—SLCO2A1—brain—nicotine dependence	0.00882	0.0241	CbGeAlD
Furosemide—CA2—cardiovascular system—nicotine dependence	0.00869	0.0237	CbGeAlD
Furosemide—Hepatobiliary disease—Varenicline—nicotine dependence	0.00856	0.0135	CcSEcCtD
Furosemide—CA12—brain—nicotine dependence	0.0083	0.0227	CbGeAlD
Furosemide—CA4—midbrain—nicotine dependence	0.00818	0.0223	CbGeAlD
Furosemide—Urinary tract disorder—Varenicline—nicotine dependence	0.00803	0.0127	CcSEcCtD
Furosemide—Urethral disorder—Varenicline—nicotine dependence	0.00797	0.0126	CcSEcCtD
Furosemide—PGD—brain—nicotine dependence	0.00786	0.0215	CbGeAlD
Furosemide—Visual impairment—Varenicline—nicotine dependence	0.00783	0.0124	CcSEcCtD
Furosemide—Erythema multiforme—Varenicline—nicotine dependence	0.00769	0.0121	CcSEcCtD
Furosemide—Eye disorder—Varenicline—nicotine dependence	0.0076	0.012	CcSEcCtD
Furosemide—Tinnitus—Varenicline—nicotine dependence	0.00758	0.012	CcSEcCtD
Furosemide—CA5B—brain—nicotine dependence	0.00745	0.0203	CbGeAlD
Furosemide—Angiopathy—Varenicline—nicotine dependence	0.00738	0.0116	CcSEcCtD
Furosemide—Immune system disorder—Varenicline—nicotine dependence	0.00734	0.0116	CcSEcCtD
Furosemide—Arrhythmia—Varenicline—nicotine dependence	0.00726	0.0115	CcSEcCtD
Furosemide—Malnutrition—Varenicline—nicotine dependence	0.00708	0.0112	CcSEcCtD
Furosemide—Erythema—Varenicline—nicotine dependence	0.00708	0.0112	CcSEcCtD
Furosemide—Flatulence—Varenicline—nicotine dependence	0.00697	0.011	CcSEcCtD
Furosemide—Dysgeusia—Varenicline—nicotine dependence	0.00693	0.0109	CcSEcCtD
Furosemide—Muscle spasms—Varenicline—nicotine dependence	0.0068	0.0107	CcSEcCtD
Furosemide—CA2—midbrain—nicotine dependence	0.00678	0.0185	CbGeAlD
Furosemide—SLC22A5—midbrain—nicotine dependence	0.00667	0.0182	CbGeAlD
Furosemide—Vision blurred—Varenicline—nicotine dependence	0.00667	0.0105	CcSEcCtD
Furosemide—CA1—brain—nicotine dependence	0.00658	0.0179	CbGeAlD
Furosemide—Anaemia—Varenicline—nicotine dependence	0.00654	0.0103	CcSEcCtD
Furosemide—Agitation—Varenicline—nicotine dependence	0.0065	0.0103	CcSEcCtD
Furosemide—Vertigo—Varenicline—nicotine dependence	0.00636	0.01	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00598	0.00944	CcSEcCtD
Furosemide—Dry mouth—Varenicline—nicotine dependence	0.00589	0.0093	CcSEcCtD
Furosemide—ALB—brain—nicotine dependence	0.00578	0.0158	CbGeAlD
Furosemide—Shock—Varenicline—nicotine dependence	0.00568	0.00897	CcSEcCtD
Furosemide—Nervous system disorder—Varenicline—nicotine dependence	0.00566	0.00894	CcSEcCtD
Furosemide—Thrombocytopenia—Varenicline—nicotine dependence	0.00565	0.00893	CcSEcCtD
Furosemide—Skin disorder—Varenicline—nicotine dependence	0.00561	0.00885	CcSEcCtD
Furosemide—Hyperhidrosis—Varenicline—nicotine dependence	0.00558	0.00881	CcSEcCtD
Furosemide—SLC22A8—brain—nicotine dependence	0.00555	0.0151	CbGeAlD
Furosemide—Anorexia—Varenicline—nicotine dependence	0.00551	0.00869	CcSEcCtD
Furosemide—Hypotension—Varenicline—nicotine dependence	0.0054	0.00852	CcSEcCtD
Furosemide—CA4—brain—nicotine dependence	0.00514	0.014	CbGeAlD
Furosemide—Somnolence—Varenicline—nicotine dependence	0.00513	0.0081	CcSEcCtD
Furosemide—Decreased appetite—Varenicline—nicotine dependence	0.00502	0.00792	CcSEcCtD
Furosemide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00499	0.00787	CcSEcCtD
Furosemide—Fatigue—Varenicline—nicotine dependence	0.00498	0.00786	CcSEcCtD
Furosemide—Constipation—Varenicline—nicotine dependence	0.00494	0.0078	CcSEcCtD
Furosemide—Pain—Varenicline—nicotine dependence	0.00494	0.0078	CcSEcCtD
Furosemide—Feeling abnormal—Varenicline—nicotine dependence	0.00476	0.00751	CcSEcCtD
Furosemide—Gastrointestinal pain—Varenicline—nicotine dependence	0.00472	0.00745	CcSEcCtD
Furosemide—Urticaria—Varenicline—nicotine dependence	0.00459	0.00724	CcSEcCtD
Furosemide—Body temperature increased—Varenicline—nicotine dependence	0.00457	0.00721	CcSEcCtD
Furosemide—Abdominal pain—Varenicline—nicotine dependence	0.00457	0.00721	CcSEcCtD
Furosemide—CA2—brain—nicotine dependence	0.00426	0.0116	CbGeAlD
Furosemide—Hypersensitivity—Varenicline—nicotine dependence	0.00426	0.00672	CcSEcCtD
Furosemide—SLC22A5—brain—nicotine dependence	0.00419	0.0114	CbGeAlD
Furosemide—Asthenia—Varenicline—nicotine dependence	0.00414	0.00654	CcSEcCtD
Furosemide—Pruritus—Varenicline—nicotine dependence	0.00409	0.00645	CcSEcCtD
Furosemide—Diarrhoea—Varenicline—nicotine dependence	0.00395	0.00624	CcSEcCtD
Furosemide—Dizziness—Varenicline—nicotine dependence	0.00382	0.00603	CcSEcCtD
Furosemide—Vomiting—Varenicline—nicotine dependence	0.00367	0.0058	CcSEcCtD
Furosemide—Rash—Varenicline—nicotine dependence	0.00364	0.00575	CcSEcCtD
Furosemide—Dermatitis—Varenicline—nicotine dependence	0.00364	0.00574	CcSEcCtD
Furosemide—Headache—Varenicline—nicotine dependence	0.00362	0.00571	CcSEcCtD
Furosemide—Nausea—Varenicline—nicotine dependence	0.00343	0.00541	CcSEcCtD
